DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314,962 | -29.6% | 35,152 | -11.6% | 0.00% | -100.0% |
| Q2 2023 | $447,548 | +12.0% | 39,782 | +14.7% | 0.00% | 0.0% |
| Q1 2023 | $399,444 | -1.9% | 34,674 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $407,029 | -7.7% | 35,119 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $441,000 | +82.2% | 34,727 | -1.3% | 0.00% | – |
| Q2 2022 | $242,000 | -22.7% | 35,190 | +8.3% | 0.00% | – |
| Q1 2022 | $313,000 | -26.2% | 32,479 | -8.9% | 0.00% | – |
| Q4 2021 | $424,000 | -25.7% | 35,648 | +1.3% | 0.00% | -100.0% |
| Q3 2021 | $571,000 | -34.4% | 35,183 | -15.0% | 0.00% | 0.0% |
| Q2 2021 | $871,000 | +131.0% | 41,411 | +70.4% | 0.00% | – |
| Q1 2021 | $377,000 | -16.6% | 24,300 | +12.9% | 0.00% | -100.0% |
| Q4 2020 | $452,000 | – | 21,524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
| Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
| Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
| Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
| HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
| Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
| COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
| RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |